Recruiting Crohns Disease Studies in Hartford
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Crohn's disease (CD) is a condition that causes inflammation (swelling, redness) of the lining and wall of the small intestine, large intestine, or both. CD may be associated with abdominal cramps/pai...
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
The main purpose of this study is to evaluate the long-term efficacy of mirikizumab in pediatric participants with ulcerative colitis (UC) or Crohn's disease (CD). The study will last about 172 weeks ...
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
The purpose of this study is to evaluate the clinical and endoscopic efficacy of guselkumab in pediatric participants with Crohn's Disease (CD) at the end of maintenance therapy (Week 52) among partic...
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
Randomized, placebo-controlled dose-ranging study of 2'-FL in IBD, Crohn's Disease (CD) and ulcerative colitis (UC). The overarching hypothesis is that 2'-FL supplementation in IBD will be safe and we...
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most often affecting the bowels. It can cause many different symptoms includ...
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Study participants will be screened during the platform study and randomly assigned to receive mirikizumab or another intervention. The purpose of the mirikizumab study is to evaluate efficacy, safety...
About Crohns Disease Clinical Trials in Hartford
Crohn's disease is a chronic inflammatory bowel disease that causes inflammation anywhere in the digestive tract, most commonly in the small intestine and colon. Symptoms include abdominal pain, diarrhea, fatigue, and weight loss. Treatment includes anti-inflammatory drugs, immunosuppressants, biologics, and surgery.
There are currently 6 crohns disease clinical trials recruiting participants in Hartford, CONNECTICUT. These studies are seeking a combined 1,486 participants. Research is being sponsored by Connecticut Children's Medical Center, Eli Lilly and Company, Janssen Research & Development, LLC and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Crohns Disease Clinical Trials in Hartford — FAQ
Are there crohns disease clinical trials in Hartford?
Yes, there are 6 crohns disease clinical trials currently recruiting in Hartford, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hartford?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hartford research site will contact you about next steps.
Are clinical trials in Hartford free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hartford studies also compensate for your time and travel.
What crohns disease treatments are being tested?
The 6 active trials in Hartford are testing new therapies including novel drugs, biologics, and treatment approaches for crohns disease.
Data updated March 2, 2026 from ClinicalTrials.gov